Search

everythinglearnresearchcommunity

for

Search:↓

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Colostrum-derived exosomes can promote hair growth and may be a promising treatment for hair loss.

Different hair loss types need accurate diagnosis for proper treatment.

Light therapy may improve eye conditions by stimulating cell activity and increasing oxygen availability.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

A 2-year-old boy with a rare brain malformation may have Gomez–López-Hernández syndrome.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Topical 5-Fluorouracil can rarely cause nerve damage, especially in people with a certain genetic deficiency.

Drug repurposing shows promise for treating many medical conditions.

People with the same genetic mutation for Woodhouse-Sakati syndrome can have different symptoms.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Testosterone improves mood and thinking skills; finasteride has no effect.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.

Higher hair levels of zinc and chromium were linked to less cognitive decline in very old people.

Selenium helps prevent thyroid issues and cognitive decline in the elderly, but balance is key.

Mutations in the HEPHL1 gene cause abnormal hair and cognitive issues.

Lifestyle drugs are mainly used by wealthy people in India but could spread to others, affecting society and youth.

Finasteride use is linked to increased reports of cognitive problems, especially in younger people with hair loss.

A patient with myotonic dystrophy had several autoimmune disorders and thyroid cancer, suggesting a possible link between these conditions.

Childhood atopic dermatitis does not significantly affect general cognition.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.